(Q34039933)

30 July 2017

1 reference

title

The management of neoplastic disorders of haematopoiesis in children with Down's syndrome (English)

1 reference

30 July 2017

0 references

Lange B

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

British Journal of Haematology

30 July 2017

published in

1 reference

30 July 2017

volume

110

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

512-524

1 reference

Life expectancy in Down syndrome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Acute nonlymphocytic leukemia after transient myeloproliferative disorder in a patient with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Acute lymphoblastic leukemia and chromosome 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Transient leukemia with trisomy 21: description of a case and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Thrombopoietin level is inversely related to blast count, not platelet number, in Down syndrome neonates with transient myeloproliferative disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Acute megakaryoblastic leukaemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Bone marrow transplantation, physician bias, and Down syndrome: ethical reflections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

The AML1-ETO chimaeric transcription factor in acute myeloid leukaemia: biology and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

TRANSIENT CONGENITAL LEUKEMIA IN 7 INFANTS WITH MONGOLISM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Acute myelofibrosis in children with Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Chromosome clues to acute leukemia in Down's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Leukaemia and transient leukaemia in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

A high-fidelity physical map of human chromosome 21q in yeast artificial chromosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Prognosis of Down's syndrome with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. Nordic Society of Paediatric Haematology and Onco

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Trisomy 21 is a recurrent secondary aberration in childhood acute lymphoblastic leukemia with TEL/AML1 gene fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Acute megakaryoblastic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Down's syndrome. The possibility of a pathogenetic segment on chromosome no. 21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Down's syndrome and acute leukemia: myeloblastic or lymphoblastic? Report of forty-three cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Severe perinatal liver disease and down syndrome: An apparent relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

A survey of childhood malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Methotrexate sensitivity in Down's syndrome: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Evidence for reduced recombination on the nondisjoined chromosomes 21 in Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

DSCAM: a novel member of the immunoglobulin superfamily maps in a Down syndrome region and is involved in the development of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Megakaryoblastic leukemia and Down's syndrome: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02027.X

10.1046/J.1365-2141.2000.02027.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference